Caladan Bio
New York, United States · Founded 2023 · $5.1M raised
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- caladan.bio
- Total Funding
- $5.1M
- Last Round
- $5.1M SeedMay 2024
- Rounds
- 1
About
Developer of modular benchtop bioreactors for synthetic biology and bioprocess research, enabling high-throughput optimization with real-time monitoring.
Summary
Caladan Bio is a Biotech company based in New York, United States, founded in 2023. It has raised $5.1M in total across 1 round, most recently a $5.1M Seed round in May 2024. Investors include Twelve Below, Lerer Hippeau and Collaborative Fund.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2024
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.




